Literature DB >> 23570822

Measurement of cardiac troponin I in serum with a new high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender.

Tar-Choon Aw1, Soon-Kieng Phua, Shiow-Pin Tan.   

Abstract

BACKGROUND: As new high-sensitivity (hs) cardiac troponin (cTn) assays are introduced decision limits, based on the 99th percentile upper reference limit (99 percentile URL), for each method must be determined and from a sufficiently large cohort to mitigate against distortionary effects of high-end outliers. There is a paucity of studies with large multi-ethnic cohorts.
METHODS: We determined the 99 percentile URL in 1120 (mean age: 50.4±8.2 y) apparently healthy (no history of diabetes, hypertension, heart, lung, or renal disease) Asians (597 men aged 35-65 y, 523 women aged 40-65 y) in a pre-market hs-cTnI assay (Abbott Diagnostics).
RESULTS: Hs-cTnI performance was: limit of blank - 0.6 ng/l, limit of detection (LoD) - 1.5 ng/l; cTnI inter-assay coefficient of variation of 20% and 10% were 1.5 and 6.0 ng/l respectively. Hs-cTnI concentrations (range: 0-49.3 ng/l) were detectable (>assay LoD) in 92.3% of participants, and higher in men and individuals >50 y. All-subject, male, and female 99 percentile URL (90% CI) were 25.6 (19.6-32.6), 32.7 (21.1-47.9) and 17.9 (10.7-26.3) ng/l respectively.
CONCLUSION: This hs-cTnI assay exhibits hs performance besides gender and age differences. The all-subject 99 percentile URL values are similar to those reported from some groups but not in others. Users need to establish their own decision limits.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23570822     DOI: 10.1016/j.cca.2013.03.034

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  21 in total

Review 1.  Pre-analytic variability in cardiovascular biomarker testing.

Authors:  Roberto Cemin; Massimo Daves
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

2.  Association Between High-Sensitivity Cardiac Troponin Levels and Myocardial Ischemia During Mental Stress and Conventional Stress.

Authors:  Muhammad Hammadah; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Ayman Alkhoder; Malik Obideen; Naser Abdelhadi; Shuyang Fang; Ijeoma Ibeanu; Pratik Pimple; Heval Mohamed Kelli; Amit J Shah; Brad Pearce; Yan Sun; Ernest V Garcia; Michael Kutner; Qi Long; Laura Ward; J Douglas Bremner; Fabio Esteves; Paolo Raggi; David Sheps; Viola Vaccarino; Arshed A Quyyumi
Journal:  JACC Cardiovasc Imaging       Date:  2017-03-15

3.  Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Lori B Daniels; Paul Clopton; Christopher R deFilippi; Otto A Sanchez; Hossein Bahrami; Joao A C Lima; Russell P Tracy; David Siscovick; Alain G Bertoni; Philip Greenland; Mary Cushman; Alan S Maisel; Michael H Criqui
Journal:  Am Heart J       Date:  2015-09-28       Impact factor: 4.749

4.  High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy.

Authors:  Brendan M Everett; Tanja Zeller; Robert J Glynn; Paul M Ridker; Stefan Blankenberg
Journal:  Circulation       Date:  2015-03-30       Impact factor: 29.690

5.  High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study.

Authors:  Anoop S V Shah; Megan Griffiths; Kuan Ken Lee; David A McAllister; Amanda L Hunter; Amy V Ferry; Anne Cruikshank; Alan Reid; Mary Stoddart; Fiona Strachan; Simon Walker; Paul O Collinson; Fred S Apple; Alasdair J Gray; Keith A A Fox; David E Newby; Nicholas L Mills
Journal:  BMJ       Date:  2015-01-21

6.  Novel Index of Maladaptive Myocardial Remodeling in Hypertension.

Authors:  Vera J Goh; Thu-Thao Le; Jennifer Bryant; Jia Ing Wong; Boyang Su; Chi-Hang Lee; Chee Jian Pua; Chloe P Y Sim; Briana Ang; Tar Choon Aw; Stuart A Cook; Calvin W L Chin
Journal:  Circ Cardiovasc Imaging       Date:  2017-09       Impact factor: 7.792

7.  Establishment of a reference interval for high-sensitivity cardiac troponin I in healthy adults from the Sichuan area.

Authors:  Shunjun Li; Yue Zuo; Wenfang Huang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

8.  Asia-Pacific consensus statement on the optimal use of high-sensitivity troponin assays in acute coronary syndromes diagnosis: focus on hs-TnI.

Authors:  Jack Wei Chieh Tan; Carolyn S P Lam; Sazzli Shahlan Kasim; Tar Choon Aw; Joel M Abanilla; Wei-Ting Chang; Van Phuoc Dang; Maria Iboleon-Dy; Sari Sri Mumpuni; Arintaya Phommintikul; Manh Cuong Ta; Punkiat Topipat; Kai Hang Yiu; Louise Cullen
Journal:  Heart Asia       Date:  2017-04-07

9.  Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study.

Authors:  Muhammad Hammadah; Jeong Hwan Kim; Ayman Samman Tahhan; Bryan Kindya; Chang Liu; Yi-An Ko; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Ayman Alkhoder; Fahad Choudhary; Mohamad Mazen Gafeer; Naser Abdelhadi; Pratik Pimple; Pratik Sandesara; Bruno B Lima; Amit J Shah; Laura Ward; Michael Kutner; J Douglas Bremner; David S Sheps; Paolo Raggi; Laurence S Sperling; Viola Vaccarino; Arshed A Quyyumi
Journal:  Ann Intern Med       Date:  2018-11-06       Impact factor: 25.391

10.  Predictors and clinical implication of high-sensitivity cardiac troponin-I elevation following diagnostic cardiac catheterisations.

Authors:  Rikuta Hamaya; Taishi Yonetsu; Tadashi Murai; Yoshihisa Kanaji; Eisuke Usui; Junji Matsuda; Masahiro Hoshino; Makoto Araki; Masahiro Hada; Takayuki Niida; Sadamitsu Ichijo; Yoshinori Kanno; Tsunekazu Kakuta
Journal:  Open Heart       Date:  2017-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.